Finance

Beta
Lists
SOPH:NASDAQ
Sophia Genetics SA
$5.46
+4.20%
(+0.22) 1D
$5.47
+0.27% (+0.015)
After hours
Closed: Jun 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SOPH...
Open
$5.35
High
$5.49
Low
$5.18
Mkt. cap
391.98M
Avg. vol.
168.22K
Volume
445.06K
52-wk high
$5.70
52-wk low
$2.59
EPS
-$1.18
Beta
0.98
Shares outstanding
71.67M
No. of employees
415
Open
$5.35
High
$5.49
Low
$5.18
Mkt. cap
391.98M
Avg. vol.
168.22K
Volume
445.06K
52-wk high
$5.70
52-wk low
$2.59
EPS
-$1.18
Beta
0.98
Shares outstanding
71.67M
No. of employees
415
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to SOPH in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for SOPH in the last 3 months.
Highest
Current $5.46
$8.00 (+46.52%)
Average
$7.50 (+37.36%)
Lowest
$7.00 (+28.21%)
News stories
From sources across the web
Profile
Sophia Genetics SA is a Swiss-founded data-driven medicine software company with headquarters in Rolle, Switzerland and Boston, Massachusetts, as well as offices in France. It provides genomic and radiomic, and multimodal analysis for hospitals, laboratories, and biopharma institutions. Wikipedia
About Sophia Genetics SA
CEOJurgi Camblong
Employees415
FoundedJan 1, 2011
Headquarters-
SectorHealth care
Websitesophiagenetics.com
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.19 / -$0.24
+20.42%beat
Revenue / Est. (USD)
21.69M / 20.40M
+6.29%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
18.32M
19.46M
21.71M
21.69M
Cost of goods sold
6.05M
6.56M
7.02M
6.94M
Cost of revenue
6.05M
6.56M
7.02M
6.94M
Research and development expenses
8.49M
8.07M
8.54M
9.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.34M
22.56M
24.65M
22.57M
Operating expense
30.76M
30.77M
33.24M
32.03M
Total operating expenses
36.82M
37.32M
40.25M
38.97M
Operating income
-18.49M
-17.86M
-18.54M
-17.28M
Other non operating income
58.00K
-607.00K
90.00K
-92.00K
EBT including unusual items
-21.65M
-19.38M
-19.57M
-19.07M
EBT excluding unusual items
-21.65M
-19.38M
-19.60M
-19.07M
Income tax expense
762.00K
642.00K
-395.00K
253.00K
Effective tax rate
-3.52%
-3.31%
2.02%
-1.33%
Other operating expenses
-66.00K
143.00K
45.00K
-
Net income
-22.41M
-20.02M
-19.18M
-19.32M
Net profit margin
-122.33%
-102.87%
-88.35%
-89.09%
Earnings per share
-0.25
-0.20
-0.17
-0.19
Interest and investment income
419.00K
622.00K
381.00K
289.00K
Interest expense
-559.00K
-1.66M
-1.67M
-1.67M
Net interest expenses
-140.00K
-1.04M
-1.29M
-1.38M
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.48M
-16.77M
-18.10M
-16.13M
Gain or loss from assets sale
-
-
-
3.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer